The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2
Open accessAbstract
We have previously identified the E3 ubiquitin ligase-inducible degrader of the low density lipoprotein receptor (LDLR) (Idol) as a post-translational modulator of LDLR levels. Idol is a direct target for regulation by liver X receptors (LXRs), and its expression is responsive to cellular sterol status independent of the sterol-response element-binding proteins. Here we demonstrate that Idol also targets two closely related LDLR family members, VLDLR and ApoE receptor 2 (ApoER2), proteins implicated in both neuronal development and lipid metabolism. Idol triggers ubiquitination of the VLDLR and ApoER2 on their cytoplasmic tails, leading to their degradation. We further show that the level of endogenous VLDLR is sensitive to cellular sterol content, Idol expression, and activation of the LXR pathway. Pharmacological activation of the LXR pathway in mice leads to increased Idol expression and to decreased Vldlr levels in vivo. Finally, we establish an unexpected functional link between LXR and Reelin signaling. We demonstrate that LXR activation results in decreased Reelin binding to VLDLR and reduced Dab1 phosphorylation. The identification of VLDLR and ApoER2 as Idol targets suggests potential roles for this LXR-inducible E3 ligase in the central nervous system in addition to lipid metabolism.
AI snapshot
Written from the paper’s full text.
TL;DR
IDOL, an LXR-inducible E3 ubiquitin ligase, targets VLDLR and ApoER2 for ubiquitination and lysosomal degradation, extending its role beyond LDLR. This reduces Reelin binding and Dab1 phosphorylation, suggesting LXR-IDOL cross-talk with neuronal Reelin signaling.
Key findings
- IDOL degrades VLDLR and ApoER2 in co-transfection assays; an inactivating RING-domain mutation (C387A) abrogates this, and mutation of the conserved lysine immediately after the NPVY motif in VLDLR abolishes degradation. IDOL promotes VLDLR polyubiquitination, and lysosomal inhibitors largely block LXR-mediated Vldlr reduction.
- LXR activation reduces endogenous VLDLR/ApoER2 protein without changing mRNA. In SNB19 cells, GW3965 or T0901317 reduced VLDLR to 26 ± 4% or 22 ± 8% of control, respectively; in mice, GW3965 at 20 mg/kg/day for 3 days induced Idol and Abca1 and decreased Vldlr in skeletal muscle.
- In primary rat hippocampal neurons, LXR activation increased Abca1 and Idol mRNA/protein and decreased a Vldlr isoform. In SNB19 cells, LXR activation decreased Reelin binding; in 3T3 cells reconstituted with VLDLR or ApoER2 plus Dab1, LXR activation largely blocked Reelin-stimulated Dab1 phosphorylation without affecting total Dab1.
- IDOL degraded the locust LDLR-family receptor LpR, and Drosophila Dnr1 degraded human LDLR and VLDLR in a RING-dependent manner. IDOL did not degrade LRP1b or EGFR.
Methods
- Cell culture and transfections used HEK 293T, SNB19 glioblastoma, 3T3 fibroblasts stably producing VLDLR/ApoER2 and Dab1, and primary rat hippocampal neurons; adenoviral infection was at MOI 80, and LXR ligands GW3965 or T0901317 were typically used at 1 μM for 24 h.
- Main assays included immunoblotting, immunoprecipitation, quantitative PCR normalized to 36B4, [35S]methionine/cysteine pulse-chase metabolic labeling, Reelin binding, Dab1 phosphorylation, and site-directed mutagenesis.
- C57BL/6 mice were orally gavaged with 20 mg/kg/day LXR ligand for 3 days; tissues were collected for RNA and protein analysis. Statistics used means ± S.D. and two-tailed Student’s t test with p < 0.05 considered significant.
Limitations
- Stated: whether IDOL modulates the Reelin pathway in vivo is unknown; whether IDOL and PCSK9 functionally cooperate remains to be seen; and whether Idol contributes to the neuronal migration defect in LXR-null mice remains to be seen.
- Evident: many mechanistic conclusions rely on overexpression/co-transfection in immortalized cell lines, and the in vivo evidence for VLDLR degradation is in skeletal muscle, whereas the Reelin/Dab1 functional link is shown only in cell culture.
- Evident: endogenous Idol detection is described as difficult, some supporting data are supplemental, and no human data are presented.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
24 of 44 cited sources checked · 19 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Idol is not regulated by SREBPs.
“Unlike the LDLR and PCSK9 genes, Idol is not regulated by SREBPs.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] Zelcer, 2009, Science source
- Interpretationown data
These observations are consistent with Idol-dependent lysosomal degradation of the VLDLR.
“These observations are consistent with Idol-dependent lysosomal degradation of the VLDR as we recently proposed for the LDLR (13).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] Zelcer, 2009, Science source
- Premisecitation
LXR null mice have substantially reduced Idol expression.
“Because the formation of vertical processes emanating from these cells requires proper Reelin signaling (39) and the LXR null mice have substantially reduced Idol expression (13), it remains to be seen whether Idol contributes to the observed migratory defect.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [13] Zelcer, 2009, Science source
- Premisecitation
A mutant LDLR lacking the intracellular domain is resistant to IDOL-mediated degradation.
“We have previously found that a mutant LDLR lacking the intracellular domain is resistant to IDOL-mediated degradation (13).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] Zelcer, 2009, Science source
- Findingcitation
Ligand-activated LXR decreases VLDLR and APOER2 protein levels in 3T3 fibroblasts stably expressing these receptors.
“In similar studies, we also found that ligand-activated LXR decreased the level of VLDLR and APOER2 in 3T3 fibroblasts stably expressing these receptors (Fig. 1C) (22).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [22] Mayer, 2006, Mol. Cell. Biol. source
- Premisecitation
The D. melanogaster Dnr1 gene is a distant homolog of mammalian IDOL.
“The D. melanogaster Dnr1 gene is a distant homolog of mammalian IDOL (28).”
- Also stated in: § DISCUSSION · plain
“The D. melanogaster Dnr1 gene is a highly divergent homolog of mammalian IDOL (28).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [28] Foley, 2004, PLoS Biol. source
The Results section (Figure 4A; page unavailable) compares Dnr1’s amino acid sequence with human MIR, and the accompanying text calls Dnr1 a conserved protein. Our copy does not identify human MIR as IDOL or describe the relationship to IDOL specifically, so it supports a human sequence similarity but not the named homolog in the claim. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Also stated in: § DISCUSSION · plain
- Findingown data
An inactivating point mutation in the IDOL RING domain (C387A) abrogates the effect of IDOL on VLDLR and ApoER2.
“Introducing an inactivating point mutation in the IDOL RING domain (C387A) (13) abrogated the effect on these receptors.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] Zelcer, 2009, Science source
- Premisecitation
Phosphorylation of Dab1 downstream of VLDLR and ApoER2 is not limited to the CNS.
“Furthermore, the phosphorylation of Dab1 downstream of the VLDLR and ApoER2 is not limited to the CNS.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [40] Yang, 2009, Proc. Natl. Acad. Sci. U.S.A. source
The Results and Discussion show APC-induced Dab1 phosphorylation downstream of ApoER2 in U937 monocytic cells, establishing that this signaling occurs outside the CNS. They do not establish Dab1 phosphorylation downstream of VLDLR outside the CNS; the Discussion instead reports that APC did not bind soluble VLDLR. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Findingown data
Treatment of primary rat neurons with an LXR ligand increased the mRNA and protein levels of Idol.
“Treatment of primary rat neurons with an LXR ligand increased the mRNA and protein levels of Abca1 and Idol, whereas expression of Vldlr did not change (Fig. 5A).”
- Also stated in: § DISCUSSION · plain
“IDOL is expressed in neurons and is induced by LXR agonists in these cells both at the mRNA and protein levels.”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · plain
- Findingown data
Induction of Idol expression in mice by GW3965 is similar in magnitude to induction of Abca1.
“Induction of Idol expression in these tissues was of a similar magnitude to that observed for the canonical LXR target gene Abca1.”
Quote in the paperNot a substantial claim - Findingown data
LXR activation decreases VLDLR protein in skeletal muscle of mice.
“Concomitantly, we observed a decrease of VLDLR in skeletal muscle from these mice in response to LXR activation (Fig. 2, B and C).”
Quote in the paperSubstantial claim - Findingown data
The VLDLR isoform lacking the O-linked glycosylation domain, which runs with higher mobility in these cells, was most dramatically decreased in response to LXR activation.
“We found that the isoform lacking the O-linked glycosylation domain, which runs with higher mobility in these cells, was most dramatically decreased in response to LXR activation (Fig. 5B and supplemental Fig. S6).”
Quote in the paperNot a substantial claim - Findingown data
IDOL homologs are found in both vertebrate and nonvertebrate species.
“We identified IDOL homologs in both vertebrate and nonvertebrate species (supplemental Fig. S3).”
- Also stated in: § DISCUSSION · plain
“IDOL itself is also highly evolutionarily conserved, with homologs found in both vertebrates and nonvertebrates.”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · plain
- Findingown data
In the presence of active Idol, polyubiquitinated VLDLR appears.
“In the presence of active Idol, we observed the appearance of polyubiquitinated VLDLR (Fig. 4C).”
Quote in the paperSubstantial claim - Findingnone given
The function of Idol is evolutionarily conserved.
“We further show that the function of Idol is evolutionarily conserved”
Quote in the paperNot a substantial claim - Findingown data
Activation of LXR in these cells had no influence on total Dab1 levels.
“Activation of LXR in these cells largely blocked this Reelin-dependent effect but had no influence on total Dab1 levels (Fig. 5D).”
Quote in the paperNot a substantial claim - Findingnone given
IDOL recognizes the intracellular tail of the LDLR family receptors.
“IDOL, on the other hand, recognizes the intracellular tail of these receptors.”
Quote in the paperSubstantial claim - Findingown data
Idol did not impact the translation of the VLDLR.
“Pulse-chase metabolic labeling experiments revealed that Idol did not impact the translation of the VLDLR (Fig. 4B).”
Quote in the paperSubstantial claim - Findingown data
Activation of the LXR pathway in SNB19 cells with GW3965 or T0901317 decreased the level of the VLDLR to 26 ± 4 or 22 ± 8% of control treated cells, respectively.
“Activation of the LXR pathway in these cells with the two different ligands GW3965 and T0901317 decreased the level of the VLDLR to 26 ± 4 or 22 ± 8% of the control treated cells, respectively (Fig. 5C).”
Quote in the paperSubstantial claim - Findingown data
Vldlr level is increased in the brains of mice lacking LXRs.
“Conversely, we found that the level of Vldlr is increased in the brains of mice lacking LXRs (supplemental Fig. S1).”
Quote in the paperSubstantial claim - Findingown data
IDOL was unable to inhibit the IMD pathway in S2 cells.
“However, despite the fact that both Dnr1 and IDOL degrade the LDLR and VLDLR, IDOL was unable to inhibit the IMD pathway in S2 cells (supplemental Fig. S4).”
- Also stated in: § DISCUSSION · hedged
“However, our data indicate that IDOL was unable to attenuate the IMD pathway when stably expressed in S2 macrophage-like cells, suggesting that this capacity has been lost during evolution.”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · hedged
- Findingown data
Pharmacological blocking of the proteasome did not result in increased ubiquitination of the VLDLR.
“Pharmacological blocking of the proteosome did not result in increased ubiquitination of the VLDLR and did not impair degradation of the receptor by Idol (Fig. 4C).”
Quote in the paperSubstantial claim - Findingown data
Sequence comparison of the receptors targeted by IDOL reveals that a limited region surrounding the NPVY endocytosis motif is highly conserved.
“Sequence comparison of the receptors targeted by IDOL reveals that a limited region surrounding the NPVY endocytosis motif is highly conserved.”
Quote in the paperSubstantial claim - Findingown data
Pharmacological blocking of the proteasome did not impair degradation of the VLDLR by Idol.
“Pharmacological blocking of the proteosome did not result in increased ubiquitination of the VLDLR and did not impair degradation of the receptor by Idol (Fig. 4C).”
Quote in the paperSubstantial claim - Findingown data
Adenoviral expression of Idol in SNB19 cells decreases endogenous Vldlr levels.
“Adenoviral expression of Idol in SNB19 cells had a similar effect (Fig. 4A).”
- Also stated in: § RESULTS · plain
“A, adenovirally mediated expression of Idol in SNB19 cells leads to a decreased level of endogenous Vldlr.”
Quote in the paperSubstantial claim - Also stated in: § RESULTS · plain
- Findingown data
Idol triggers ubiquitination of VLDLR and ApoER2 on their cytoplasmic tails, leading to their degradation.
“Idol triggers ubiquitination of the VLDLR and ApoER2 on their cytoplasmic tails, leading to their degradation.”
Quote in the paperSubstantial claim- Rests on an assumption: The conserved lysine residue adjacent to the NPVY motif in VLDLR and ApoER2 is the site of IDOL-mediated ubiquitination.
- Findingown data
Blocking lysosomal function with ammonium chloride or chloroquine largely inhibited the LXR-mediated reduction of Vldlr abundance.
“Blocking lysosomal function with the lysosomotropic agents ammonium chloride or chloroquine, on the other hand, largely inhibited the LXR-mediated reduction of Vldlr abundance (supplemental Fig. S5).”
Quote in the paperSubstantial claim - Findingown data
In the absence of Idol, the VLDLR rapidly matures as evidenced by the appearance of a lower mobility band representing the fully glycosylated receptor.
“In the absence of Idol, the VLDLR rapidly matures as evidenced by the appearance of a lower mobility band representing the fully glycosylated receptor.”
Quote in the paperSubstantial claim - Findingown data
Treatment of primary rat neurons with an LXR ligand increased the mRNA and protein levels of Abca1.
“Treatment of primary rat neurons with an LXR ligand increased the mRNA and protein levels of Abca1 and Idol, whereas expression of Vldlr did not change (Fig. 5A).”
Quote in the paperNot a substantial claim - Findingown data
Decrease in VLDLR level was mirrored by a decrease in Reelin binding.
“Furthermore, this was mirrored by a decrease in Reelin binding.”
Quote in the paperSubstantial claim - Findingown data
Of the mammalian members tested, only the LDLR, VLDLR, and ApoER2 appear to be IDOL targets.
“Of the mammalian members tested, only the LDLR, VLDLR, and ApoER2 appear to be IDOL targets.”
Quote in the paperSubstantial claim - Findingown data
Activation of LXR in these cells largely blocked the Reelin-dependent stimulation of Dab1 phosphorylation.
“Activation of LXR in these cells largely blocked this Reelin-dependent effect but had no influence on total Dab1 levels (Fig. 5D).”
Quote in the paperSubstantial claim - Findingown data
The most prominent effect of Idol on VLDLR and ApoER2 is on the mature (fully glycosylated) proteins.
“Consistent with our previous studies of LDLR degradation, the most prominent effect of Idol was observed on the level of the mature (fully glycosylated) VLDLR and ApoER2 proteins.”
Quote in the paperNot a substantial claim- Rests on an assumption: The two VLDLR bands detected in SNB19 cells represent the precursor and mature (fully glycosylated) receptor.
- Findingcitation
The lysine residue following the NPVY motif is essential for ubiquitination by IDOL.
“The lysine residue following this motif is essential for ubiquitination by IDOL (Ref. 13 and Fig. 4D).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ref. 13
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
The cysteine residue that serves as a second target for Idol in the LDLR is not conserved in either the VLDLR or ApoER2.
“Note that the cysteine residue that serves as a second target for Idol in the LDLR is not conserved in either the VLDLR or ApoER2 (Fig. 3A).”
Quote in the paperNot a substantial claim - Findingown data
Idol expression prevented the appearance of the mature form of the VLDLR.
“Idol expression prevented the appearance of the mature form of the receptor, consistent with our prior observations with the LDLR.”
Quote in the paperSubstantial claim - Findingown data
Both human and mouse IDOL reduce protein levels of VLDLR and ApoER2, in addition to LDLR, in co-transfection experiments in HEK 293 cells.
“In co-transfection experiments in HEK 293 cells, we found that both human and mouse IDOL reduce the level of the VLDLR and ApoER2, in addition to LDLR (Fig. 3B).”
Quote in the paperSubstantial claim - Findingown data
Mutation of all three lysine residues present in the intracellular tail of the VLDLR abolished degradation by Idol.
“Mutation of all three lysine residues present in the intracellular tail of the VLDLR abolished degradation by Idol (Fig. 4D).”
Quote in the paperSubstantial claim - Findingown data
Treatment of primary rat neurons with an LXR ligand did not change Vldlr expression.
“Treatment of primary rat neurons with an LXR ligand increased the mRNA and protein levels of Abca1 and Idol, whereas expression of Vldlr did not change (Fig. 5A).”
Quote in the paperNot a substantial claim - Findingown data
Mutating the highly conserved lysine residue immediately following the NPVY endocytotic motif abolished degradation by Idol.
“Remarkably, mutating the highly conserved lysine residue immediately following the NPVY endocytotic motif resulted in the same outcome, indicating that this residue is the sole target for Idol-mediated ubiquitination.”
Quote in the paperSubstantial claim - Findingown data
Dnr1 degrades human LDLR and VLDLR in a manner dependent on an intact RING domain.
“Remarkably, Dnr1 degraded the human LDLR and VLDLR dependent on an intact RING domain (Fig. 3E).”
- Also stated in: § DISCUSSION · plain
“Nevertheless, Dnr1 degraded the LDLR and VLDLR in co-transfection assays in a RING-dependent manner.”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · plain
- Findingown data
Idol targets VLDLR and ApoER2 for degradation.
“Here we demonstrate that Idol also targets two closely related LDLR family members, VLDLR and ApoE receptor 2 (ApoER2), proteins implicated in both neuronal development and lipid metabolism.”
Quote in the paperSubstantial claim - Findingown data
Under several conditions, the activity of IDOL on the LDLR seems to be independent of PCSK9.
“Of note, under several conditions the activity of IDOL on the LDLR seems to be independent of PCSK9.”
Quote in the paperNot a substantial claim - Findingown data
Replacing the natural intracellular domain of APP with that of the LDLR allows IDOL to target the chimeric receptor for destruction.
“We show here that replacing the natural intracellular domain of APP, which is not targeted by IDOL, with that of the LDLR allowed IDOL to target the chimeric receptor for destruction (Fig. 3C).”
Quote in the paperSubstantial claim- Rests on an assumption: APP is not targeted by IDOL.
- Interpretationcitation
The substrate specificities of IDOL and PCSK9 overlap.
“Our results further indicate that the substrate specificities of IDOL and PCSK9 overlap, because previous studies have suggested that PCSK9 can also reduce the protein levels of VLDLR and ApoER2 (26, 27).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationown data
The capacity of IDOL to attenuate the IMD pathway has been lost during evolution.
“However, our data indicate that IDOL was unable to attenuate the IMD pathway when stably expressed in S2 macrophage-like cells, suggesting that this capacity has been lost during evolution.”
Quote in the paperSubstantial claim - Interpretationown data
The ability of IDOL to degrade members of the LDLR family is an evolutionarily conserved mechanism to modulate lipoprotein uptake.
“In conclusion, these results suggest that the ability of IDOL to degrade members of the LDLR family is an evolutionarily conserved mechanism to modulate lipoprotein uptake.”
Quote in the paperSubstantial claim- Rests on an assumption: The function of members of the LDLR family of receptors is evolutionarily conserved.
- Interpretationown data
The LXR-IDOL pathway targets the VLDLR and ApoER2 for degradation.
“In conclusion, we demonstrate here that the LXR-IDOL pathway targets the VLDLR and ApoER2 for degradation.”
Quote in the paperSubstantial claim - Interpretationown data
The ability of LXR to modulate the levels of the neuronal lipoprotein receptors VLDLR and ApoER2 appears to have a functional consequence for Reelin signaling.
“Thus, the ability of LXR to modulate the levels of the neuronal lipoprotein receptors VLDLR and ApoER2 appears to have a functional consequence for Reelin signaling.”
Quote in the paperSubstantial claim - Premisecitation
Only the combined loss of both VLDLR and ApoER2 results in severely impaired neuronal positioning.
“Because only the combined loss of both receptors results in severely impaired neuronal positioning (16), the ability of IDOL to simultaneously target both receptors for degradation may allow it to modulate this pathway.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Trommsdorff, 1999, Cell source
- Interpretationown data
IDOL modulates the Reelin pathway by controlling the levels of VLDLR and ApoER2.
“In these cells IDOL has been proposed to inhibit neurite outgrowth (37) and, as we show here, to modulate the Reelin pathway by controlling the levels of VLDLR and ApoER2.”
Quote in the paperSubstantial claim - Interpretationown data
The highly conserved lysine residue immediately following the NPVY endocytotic motif is the sole target for Idol-mediated ubiquitination of the VLDLR.
“Remarkably, mutating the highly conserved lysine residue immediately following the NPVY endocytotic motif resulted in the same outcome, indicating that this residue is the sole target for Idol-mediated ubiquitination.”
Quote in the paperSubstantial claim - Interpretationreasoning
The identification of VLDLR and ApoER2 as Idol targets suggests potential roles for this LXR-inducible E3 ligase in the central nervous system in addition to lipid metabolism.
“The identification of VLDLR and ApoER2 as Idol targets suggests potential roles for this LXR-inducible E3 ligase in the central nervous system in addition to lipid metabolism.”
Quote in the paperSubstantial claim - Interpretationown data
The findings are consistent with a post-translational effect on receptor levels.
“These findings are consistent with a post-translational effect on receptor levels.”
Quote in the paperSubstantial claim - Interpretationreasoning
The LXR pathway's post-translational regulation of VLDLR and ApoER2 is the result of transcriptional induction of the E3 ubiquitin ligase IDOL that targets these receptors for lysosomal degradation.
“Mechanistically, this is the result of transcriptional induction of the E3 ubiquitin ligase IDOL that targets these receptors for lysosomal degradation.”
Quote in the paperSubstantial claim- Rests on an assumption: Idol is an E3 ubiquitin-ligase.
- Interpretationreasoning
All of the IDOL recognition determinants are encoded within the intracellular domain of the LDLR.
“This implies that all of the IDOL recognition determinants are encoded within this region.”
Quote in the paperSubstantial claim- Rests on an assumption: The intracellular domain of the LDLR is both required and sufficient for recognition by IDOL.
- Interpretationcitation
A plausible explanation for the loss of IMD pathway inhibition by IDOL is that the region in Dnr1 identified as crucial for interaction with Dredd is absent in IDOL.
“A plausible explanation for this lies in the fact that the region in Dnr1 identified as crucial for interaction with Dredd is absent in IDOL (41).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41] Primrose, 2007, J. Cell Sci. source
- Interpretationown data
The LXR pathway post-translationally regulates the levels of VLDLR and ApoER2, in addition to modulating the LDLR.
“In this study we demonstrate that, in addition to modulating the LDLR, the LXR pathway also post-translationally regulates the levels of the related receptors VLDLR and ApoER2.”
Quote in the paperSubstantial claim - Premisecitation
The high degree of evolutionary conservation within the LDLR family of receptors prompted the investigation of substrate specificity of IDOL.
“Our investigation of the substrate specificity of IDOL was largely prompted by the high degree of evolutionary conservation within the LDLR family of receptors (14).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [14] Herz, 2002, Annu. Rev. Biochem. source
- Interpretationown data
LXR signaling can post-transcriptionally modulate the protein levels of VLDLR and APOER2.
“Cumulatively, these results suggest that LXR signaling can post-transcriptionally modulate the protein levels of the VLDLR and APOER2.”
Quote in the paperSubstantial claim - Interpretationown data
Activation of LXR reduces protein levels of VLDLR and ApoER2 both in vitro and in vivo without affecting their transcript levels.
“Cumulatively, our results suggest that activation of LXR reduces protein levels of VLDLR and ApoER2 both in vitro and in vivo without affecting their transcript levels.”
Quote in the paperSubstantial claim - Interpretationown data
This is the first observation that activation of LXR increases the level of endogenous Idol protein.
“Interestingly, this is the first observation that activation of LXR increases the level of endogenous Idol protein.”
Quote in the paperNot a substantial claim - Interpretationreasoning
LXR-dependent induction of Idol defines a complementary but distinct pathway for sterol-dependent inhibition of cellular cholesterol uptake through the LDLR.
“Therefore, LXR-dependent induction of Idol defines a complementary but distinct pathway for sterol-dependent inhibition of cellular cholesterol uptake through the LDLR.”
Quote in the paperSubstantial claim - Interpretationcitation
The ability of IDOL to simultaneously target both VLDLR and ApoER2 for degradation may allow it to modulate the Reelin pathway.
“Because only the combined loss of both receptors results in severely impaired neuronal positioning (16), the ability of IDOL to simultaneously target both receptors for degradation may allow it to modulate this pathway.”
Quote in the paperSubstantial claim
- May combine two claims. 25
- Classified as probably not a substantial claim. 23
May combine two claims.
PremisecitationKnockdown of Idol expression increases LDLR protein and LDL uptake.
“Conversely, knockdown of Idol expression leads to an increase in LDLR protein and LDL uptake.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] Zelcer, 2009, Science source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSeveral isoforms of the VLDLR have been observed in neurons.
“Several isoforms of the VLDLR have been observed in neurons (26, 29).”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationOverexpression of Idol reduces LDLR protein levels in vitro and in vivo and inhibits LDL uptake.
“Overexpression of Idol potently reduces LDLR protein levels in vitro and in vivo and inhibits LDL uptake.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] Zelcer, 2009, Science source
Classified as probably not a substantial claim.
PremisecitationReelin interaction with the VLDLR and ApoER2 is critical during development because it properly directs the positioning of neurons.
“Reelin interaction with the VLDLR and ApoER2 is critical during development because it properly directs the positioning of neurons (16, 20, 21).”
Quote in the paperSubstantial claim2 of 3 sources checkedMay combine two claims.
PremisecitationIdol triggers ubiquitination of the LDLR on conserved residues in its intracellular tail, leading to degradation of the receptor.
“Idol triggers ubiquitination of the LDLR on conserved residues in its intracellular tail, leading to degradation of the receptor.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] Zelcer, 2009, Science source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe intracellular domain of the LDLR forms a scaffold for protein-protein interactions essential for proper function and trafficking of the receptor.
“The intracellular domain of the LDLR forms a scaffold for protein-protein interactions essential for proper function and trafficking of the receptor (42).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [42] Gotthardt, 2000, J. Biol. Chem. source
The Discussion reports adaptor and scaffold proteins interacting with LDL receptor family cytoplasmic tails, and the Results show that DAB1 binding to the LDL receptor tail affects its endocytosis. But the Results explicitly say there is no indication that DAB1 binding to the LDL receptor tail has a critical physiological function in vivo. The claim’s assertion that these interactions are essential for proper LDLR function and trafficking is therefore stronger than the evidence. (LLM, conf=0.89)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIdol is a transcriptional target of LXRs and a post-transcriptional regulator of the LDLR pathway.
“We have recently identified the E3 ubiquitin ligase Idol (inducible degrader of the LDLR) as a transcriptional target of LXRs and a post-transcriptional regulator of the LDLR pathway (13).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] Zelcer, 2009, Science source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationVLDLR and ApoER2 interact with Reelin, leading to phosphorylation of Dab1.
“A body of evidence demonstrates that the VLDLR and ApoER2 interact with an extracellular ligand, Reelin, leading, as a first event, to phosphorylation of the adaptor molecule Dab1 (20, 21).”
Quote in the paperNot a substantial claim2 of 2 sources checkedClassified as probably not a substantial claim.
PremisecitationThe formation of vertical processes emanating from radial glia cells requires proper Reelin signaling.
“Because the formation of vertical processes emanating from these cells requires proper Reelin signaling (39) and the LXR null mice have substantially reduced Idol expression (13), it remains to be seen whether Idol contributes to the observed migratory defect.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [39] Hartfuss, 2003, Development source
The Discussion says Reelin is a necessary factor for radial process elongation or maintenance in the reeler mutant cortex. But it also says some radial glia extend long processes without Reelin and that radial glia in other CNS regions do not require its signaling. The claim omits this regional and cellular qualification. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDnr1 is an inhibitor of the inflammatory IMD pathway in flies.
“Dnr1 is an inhibitor of the inflammatory IMD pathway in flies (28).”
- Also stated in: § DISCUSSION · hedged
“Dnr1 has been reported to inhibit the IMD pathway in flies.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [28] Foley, 2004, PLoS Biol. source
- Also stated in: § DISCUSSION · hedged
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMice lacking LXR display disrupted neuronal migration, which Fan et al. attributed to a reduction in the number of vertical processes emanating from radial glia cells.
“Intriguingly, despite having a similar Reelin level, mice lacking LXR display disrupted neuronal migration, which Fan et al. (38) attributed to a reduction in the number of vertical processes emanating from the radial glia cells.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [38] Fan, 2008, Proc. Natl. Acad. Sci. U.S.A. source
Classified as probably not a substantial claim.
PremisecitationThe VLDLR and ApoER2 are critical for neuronal migration during development.
“In addition to their proposed roles in metabolism, the VLDLR and ApoER2 are critical for neuronal migration during development (16, 20, 21).”
Quote in the paperSubstantial claim2 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn macrophages, ligation of ApoER2 by activated protein C results in Dab1-dependent signaling events.
“In macrophages, ligation of ApoER2 by activated protein C results in Dab1-dependent signaling events (40).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [40] Yang, 2009, Proc. Natl. Acad. Sci. U.S.A. source
The Results report that activated protein C induced Dab1 phosphorylation in U937 cells and that ApoER2 knockdown abolished it. The Discussion describes this as ApoER2-mediated, Dab1-dependent signaling, but the study used a monocytic cell line rather than macrophages, so the claim extends the finding to a different cell population. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataA 70% reduction in Idol expression increases basal VLDLR and largely abrogates the ability of activated LXR to reduce VLDLR in 3T3-VLDLR cells.
“A 70% reduction in Idol expression resulted in an increased basal level of VLDLR in 3T3-VLDLR cells and largely abrogated the ability of activated LXR to reduce the level of this receptor (supplemental Fig. S2).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataActivation of the LXR pathway leads to decreased levels of VLDLR and ApoER2 protein without an effect on the respective transcript.
“Activation of the LXR pathway leads to decreased levels of VLDLR and ApoER2 protein without an effect on the respective transcript (Fig. 1, A–C, and not shown).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPharmacological dosing of mice with GW3965 induces the LXR pathway in metabolic tissues without affecting VLDLR expression.
“Pharmacological dosing of mice with GW3965 led to induction of the LXR pathway in metabolic tissues without affecting VLDLR expression (Fig. 2A).”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationIDOL degrades the LpR, an ancient LDLR-related receptor from the migrating locust (Locusta migratoria) that is important for lipoprotein uptake in this species.
“Accordingly, we find that IDOL degrades the LpR, an ancient LDLR-related receptor from the migrating locust (Locusta migratoria) that is important for lipoprotein uptake in this species (Fig. 3, A and D) (25).”
- Also stated in: § DISCUSSION · plain
“Remarkably, IDOL was also able to degrade an ancient LDLR family member important for lipoprotein uptake in the migrating locust.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] Van Hoof, 2002, J. Cell Sci. source
- Also stated in: § DISCUSSION · plain
May combine two claims.
FindingreasoningIDOL degrades the LDLR in cells that do not express PCSK9 (e.g. macrophages) as well as endocytosis mutants of the LDLR, VLDLR, and ApoER2.
“IDOL degrades the LDLR in cells that do not express PCSK9 (e.g. macrophages) as well as endocytosis mutants of the LDLR, VLDLR, and ApoER2.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDepletion of oxysterol LXR agonists by Sult2b1 in SNB19 cells decreases LXR target gene expression and has no effect on VLDLR expression.
“Depletion of oxysterol LXR agonists by Sult2b1 in SNB19 cells decreased expression of LXR target genes as expected and had no effect on VLDLR expression (Fig. 1D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPharmacological activation of the LXR pathway in mice increases Idol expression and decreases Vldlr levels in vivo.
“Pharmacological activation of the LXR pathway in mice leads to increased Idol expression and to decreased Vldlr levels in vivo.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLXR ligand treatment decreases VLDLR protein without decreasing VLDLR mRNA.
“This reduction was not a result of decreased VLDLR expression. Whereas expression of the LXR target genes ABCA1 and IDOL were increased, that of the VLDLR remained unchanged (Fig. 1B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIDOL does not reduce LRP1b or EGFR levels.
“Unexpectedly, IDOL did not reduce the level of LRP1b, as may have been predicted based on sequence homology (Fig. 3, A and B) or the level of another NPVY-containing receptor, the epidermal growth factor receptor (data not shown).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataEndogenous VLDLR level is sensitive to cellular sterol content, Idol expression, and activation of the LXR pathway.
“We further show that the level of endogenous VLDLR is sensitive to cellular sterol content, Idol expression, and activation of the LXR pathway.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLXR activation results in decreased Reelin binding to VLDLR and reduced Dab1 phosphorylation.
“We demonstrate that LXR activation results in decreased Reelin binding to VLDLR and reduced Dab1 phosphorylation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe presence of the lysine residue following the NPVY motif is not sufficient for IDOL targeting, because LRP1b is not targeted by IDOL.
“However, its presence is not sufficient, because LRP1b is not targeted by IDOL.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data3T3 cells stably reconstituted with VLDLR or ApoER2 and Dab1 responded to Reelin in a similar fashion to primary neurons, with Reelin binding strongly stimulating Dab1 phosphorylation.
“Functionally, these cells responded to Reelin in a similar fashion to primary neurons, with Reelin binding strongly stimulating Dab1 phosphorylation (Fig. 5D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTreatment of SNB19 glioblastoma cells with GW3965 or T0901317 increases ABCA1 and decreases endogenous VLDLR protein levels.
“Treatment of these cells with GW3965 or T0901317 increased the level of the LXR-responsive protein ABCA1 and concomitantly decreased the levels of the endogenous VLDLR (Fig. 1A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSult2b1 depletion increases VLDLR protein, and this increase is reversed by a synthetic LXR ligand.
“Nevertheless, this treatment increased VLDLR protein, and this effect was reversed by a synthetic LXR ligand (Fig. 1E).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationDnr1 inhibits the IMD pathway by blocking the activity of the fly caspases-8 homolog, Dredd.
“Dnr1 inhibits the IMD pathway by blocking the activity of the fly caspases-8 homolog, Dredd (41).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41] Primrose, 2007, J. Cell Sci. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe immunoblots shown are representative of at least two independent experiments.
“The blots are representative of at least two independent experiments.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningIt is highly unlikely that IDOL and PCSK9 directly interact.
“It is highly unlikely that these two proteins directly interact.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationVLDLR and ApoER2 have a critical role in the neuronal Reelin pathway essential for proper neuronal positioning and brain development.
“studies in recent years have established a critical role for VLDLR and ApoER2 in the neuronal Reelin pathway that is essential for proper neuronal positioning and brain development (16–19).”
Quote in the paperSubstantial claim0 of 4 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenStatistical analysis was done with a two-tailed Student's t test, and p < 0.05 was considered statistically significant.
“Statistical analysis was done with a two-tailed Student's t test. A probability value of p < 0.05 was considered statistically significant.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe animal experiments were conducted in accordance with institutional guidelines.
“The animal experiments were conducted in accordance with institutional guidelines.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPCSK9 is a secreted protein that binds the ecto-domain of the receptors and promotes their endocytosis and lysosomal degradation.
“PCSK9 is a secreted protein that binds the ecto-domain of the receptors and promotes their endocytosis and lysosomal degradation.”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenRestriction digest analysis and DNA sequencing were used to verify the correctness of all constructs used in this study.
“Restriction digest analysis and DNA sequencing were used to verify the correctness of all of the constructs used in this study.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe ability of the LXR-IDOL pathway to target multiple members of the LDLR superfamily suggests a potential role for this pathway in processes beyond lipid metabolism.
“The ability of the LXR-IDOL pathway to target multiple members of the LDLR superfamily suggests a potential role for this pathway in processes beyond lipid metabolism.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPCSK9 post-translationally modulates the levels of LDLR, VLDLR, and ApoER2.
“Similar to IDOL, the secreted protein PCSK9 also post-translationally modulates the levels of the LDLR, VLDLR, and ApoER2 (26, 27).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationVLDLR and ApoER2 share the highest overall sequence homology with LDLR among the LDLR family.
“Among the LDLR family of proteins, the VLDLR (very low density lipoprotein receptor) and ApoER2 (also known as LRP8) share the highest overall sequence homology with the LDLR (14).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Herz, 2002, Annu. Rev. Biochem. source
Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing).
InterpretationreasoningThe overlapping substrate specificities of IDOL and PCSK9 raise the possibility that they act in a concerted fashion.
“The overlapping substrate specificities of IDOL and PCSK9 raise the intriguing possibility that they act in a concerted fashion.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningIn addition to potential roles in metabolism, IDOL may also have a role in neurons during development.
“This suggests that in addition to potential roles in metabolism, IDOL may also have a role in neurons during development.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe intracellular domain is both necessary and sufficient to direct Idol-dependent degradation of plasma membrane proteins.
“This result demonstrates that the intracellular domain is both necessary and sufficient to direct Idol-dependent degradation of plasma membrane proteins.”
Quote in the paperSubstantial claim- Rests on an assumption: APP is not targeted by IDOL.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningThe LXR-IDOL pathway may be involved not only in Reelin signaling in the CNS but also in peripheral Dab1-dependent processes.
“This raises the possibility that the LXR-IDOL pathway may be involved not only in Reelin signaling in the CNS but also in peripheral Dab1-dependent processes.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The two VLDLR bands detected in SNB19 cells represent the precursor and mature (fully glycosylated) receptor.
“we detect the VLDLR as two bands that likely represent the precursor and mature (fully glycosylated) receptor (Fig. 1A).”
The paper relies on this without support.
APP is not targeted by IDOL.
“replacing the natural intracellular domain of APP, which is not targeted by IDOL, with that of the LDLR allowed IDOL to target the chimeric receptor for destruction (Fig. 3C).”
The paper relies on this without support.
The conserved lysine residue adjacent to the NPVY motif in VLDLR and ApoER2 is the site of IDOL-mediated ubiquitination.
“Because this residue is highly conserved in the VLDLR and ApoER2, we tested whether IDOL underlies the LXR-mediated reduction of these receptors.”
The paper relies on this without support.
The function of members of the LDLR family of receptors is evolutionarily conserved.
“The function of members of the LDLR family of receptors is evolutionarily conserved.”
The paper relies on this without support.
Idol is an E3 ubiquitin-ligase.
“Because Idol is an E3 ubiquitin-ligase, we tested whether the VLDLR was ubiquitinated by Idol.”
The paper relies on this without support.
The intracellular domain of the LDLR is both required and sufficient for recognition by IDOL.
“Furthermore, this domain is both required and sufficient for recognition by IDOL.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Overexpression of IDOL strongly reduces LDLR, VLDLR, and APOER2 protein levels in vitro and in vivo, whereas IDOL knockdown results in the opposite outcome.
“Briefly, overexpression of IDOL strongly reduces LDLR, VLDLR, and APOER2 protein levels in vitro and in vivo, whereas IDOL knockdown results in the opposite outcome.”
From Distinct Functional Domains Contribute to Degradation of the Low Density Lipoprotein Receptor (LDLR) by the E3 Ubiquitin Ligase Inducible Degrader of the LDLR (IDOL) (2011) · cites this paper as [13]
The Introduction reports that IDOL overexpression lowers LDLR protein in vitro and in vivo, while knockdown increases it. The Results report that IDOL reduces VLDLR and ApoER2 in cultured cells and that knockdown raises basal VLDLR in cells. The in vivo experiment instead activated LXR and measured reduced VLDLR; our copy does not show IDOL overexpression or knockdown producing the stated outcomes for all three receptors in vivo. (LLM, conf=0.87)
Experimental — accuracy not yet measuredThe predicted α-helix within the PTB domain of IDOL is highly evolutionarily conserved.
“the sequence of the predicted ␣-helix within the PTB domain of IDOL is highly evolutionarily conserved (Fig. 8C).”
From Distinct Functional Domains Contribute to Degradation of the Low Density Lipoprotein Receptor (LDLR) by the E3 Ubiquitin Ligase Inducible Degrader of the LDLR (IDOL) (2011) · cites this paper as [13]
The Discussion (page unavailable) says IDOL itself is highly evolutionarily conserved, with homologs in vertebrates and nonvertebrates. It does not establish that the sequence of a predicted α-helix within a PTB domain is conserved; searches for the helix and PTB domain found no such passage. (LLM, conf=0.78)
Experimental — accuracy not yet measuredIDOL induces post-translational modifications by ubiquitinating its substrates.
“IDOL induces post‐translational modifications by ubiquitinating its substrates, 19 , 53 but neuronal Idol deletion may also result in transcriptomic changes.”
From Deletion of neuronal <i>Idol</i> ameliorates Alzheimer's disease–related pathologies via APOE receptors (2025) · cites this paper as [53]
IDOL also targets other APOE receptors, APOER2 and VLDLR, which are key mediators of Reelin signaling.
“In addition to LDLR, IDOL also targets other APOE receptors, APOER2 and VLDLR, which are key mediators of Reelin signaling. 53”
From Deletion of neuronal <i>Idol</i> ameliorates Alzheimer's disease–related pathologies via APOE receptors (2025) · cites this paper as [53]
VLDLR and APOER2 are targets of IDOL.
“VLDLR and APOER2, other LDL receptor family members, are also the targets of IDOL.”
From Deletion of neuronal <i>Idol</i> ameliorates Alzheimer's disease–related pathologies via APOE receptors (2025) · cites this paper as [53]
IDOL controls the abundance of LDLR, VLDLR, and ApoER2 via ubiquitination, which targets the proteins for lysosomal degradation.
“IDOL controls the abundance of three proteins (LDLR, VLDLR, and ApoER2) via ubiquitination, which targets the proteins for lysosomal degradation9,13.”
From IDOL regulates systemic energy balance through control of neuronal VLDLR expression (2019) · cites this paper as [9]
IDOL promotes the degradation of ApoER2 and VLDLR in cultured cells.
“Studies in cultured cells have shown that IDOL also promotes the degradation of ApoER2 and VLDLR (Hong et al., 2010)”
From The E3 ubiquitin ligase IDOL regulates synaptic ApoER2 levels and is important for plasticity and learning (2017) · cites this paper as Hong et al., 2010
Modulation of LDLR family receptor levels by IDOL is a post-transcriptional event.
“Importantly, modulation of the levels of these receptors by IDOL is a post-transcriptional event.”
In addition to the LDLR, VLDLR and APOER2 are subject to IDOL-mediated degradation.
“We recently reported that in addition to the LDLR, two other closely related receptors, the VLDLR and APOER2, are also subject to IDOLmediated degradation (13).”
Ubiquitination of these receptors by IDOL marks them for subsequent lysosomal degradation.
“Ubiquitination of these receptors by IDOL marks them for subsequent lysosomal degradation.”
Dnr1 promotes LDLR degradation.
“which we have recently shown to also promote LDLR degradation (13).”
Lrp1b is not degraded by IDOL.
“Notably, a closely related LDLR family member, Lrp1b, is not degraded by IDOL (13).”
The intracellular tail of the LDLR is both required and sufficient for IDOL-dependent degradation.
“We have previously reported that the intracellular tail of the LDLR is both required and sufficient for IDOL-dependent degradation (11,13).”
Besides LDLR, both IDOL and PCSK9 promote the degradation of ApoER2 and VLDLR.
“Besides LDLR, both IDOL and PCSK9 also promote the degradation of ApoER2 and VLDLR (Hong et al 2010, Poirier et al 2008).”
From ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease (2022) · cites this paper as Hong et al 2010
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703 · see citing works
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
Abifadel, M., Varret, M., Rabès, J.-P., Allard, D., Ouguerram, K., Devillers, M., Cruaud, C., Benjannet, S., Wickham, L., Erlich, D., et al. (2003) · Nature Genetics · doi:10.1038/ng1161 · Cited by 2,985 · see citing works
Protein Sensors for Membrane Sterols
Goldstein, J. L., DeBose‐Boyd, R. A., & Brown, M. S. (2006) · Cell · doi:10.1016/j.cell.2005.12.022 · Cited by 1,677 · see citing works
Cohen, J., Pertsemlidis, A., Kotowski, I. K., Graham, R., Garcia, C. K., & Hobbs, H. H. (2005) · Nature Genetics · doi:10.1038/ng1509 · Cited by 1,381 · see citing works
Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A., & Herz, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80782-5 · Cited by 1,261 · see citing works
Self-citationLiver X receptors as integrators of metabolic and inflammatory signaling
Zelcer, N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27883 · Cited by 978 · see citing works
Self-citationYokoyama, C., Wang, X., Briggs, M. R., Admon, A., Wu, J., Hua, X., Goldstein, J. L., & Brown, M. S. (1993) · Cell · doi:10.1016/s0092-8674(05)80095-9 · Cited by 968 · see citing works
Hiesberger, T., Trommsdorff, M., Howell, B. W., Goffinet, A., Mumby, M. C., Cooper, J. A., & Herz, J. (1999) · Neuron · doi:10.1016/s0896-6273(00)80861-2 · Cited by 916 · see citing works
ApoE Promotes the Proteolytic Degradation of Aβ
Jiang, Q., Lee, C. Y. D., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.010 · Cited by 876 · see citing works
Self-citationLXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
Zelcer, N., Hong, C., Boyadjian, R., & Tontonoz, P. (2009) · Science · doi:10.1126/science.1168974 · Cited by 848 · see citing works
Self-citationReelin Is a Ligand for Lipoprotein Receptors
D'Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D. S., Sheldon, M., & Curran, T. (1999) · Neuron · doi:10.1016/s0896-6273(00)80860-0 · Cited by 808 · see citing works
THE LDL RECEPTOR LOCUS IN FAMILIAL HYPERCHOLESTEROLEMIA: Mutational Analysis of a Membrane Protein
Hobbs, H. H., Russell, D. W., Brown, M. S., & Goldstein, J. L. (1990) · Annual Review of Genetics · doi:10.1146/annurev.ge.24.120190.001025 · Cited by 713 · see citing works
Neuronal position in the developing brain is regulated by mouse disabled-1
Howell, B. W., Hawkes, R., Soriano, P., & Cooper, J. A. (1997) · Nature · doi:10.1038/39607 · Cited by 692 · see citing works
Scrambler and yotari disrupt the disabled gene and produce a reeler -like phenotype in mice
Sheldon, M., Rice, D. S., D'Arcangelo, G., Yoneshima, H., Nakajima, K., Mikoshiba, K., Howell, B. W., Cooper, J. A., Goldowitz, D., & Curran, T. (1997) · Nature · doi:10.1038/39601 · Cited by 638 · see citing works
Hua, X., Yokoyama, C., Wu, J. I., Briggs, M. R., Brown, M. S., Goldstein, J. L., & Wang, X. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11603 · Cited by 626 · see citing works
Garcia, C. K., Wilund, K., Arca, M., Zuliani, G., Fellin, R., Maioli, M., Calandra, S., Bertolini, S., Cossu, F., Grishin, N., et al. (2001) · Science · doi:10.1126/science.1060458 · Cited by 624 · see citing works
Maxwell, K. N., & Breslow, J. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402133101 · Cited by 613 · see citing works
Park, S. W., Moon, Y.-A., & Horton, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410077200 · Cited by 500 · see citing works
Poirier, S., Mayer, G., Benjannet, S., Bergeron, E., Marcinkiewicz, J., Nassoury, N., Mayer, H., Nimpf, J., Prat, A., & Seidah, N. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708098200 · Cited by 477 · see citing works
Self-citationLipoprotein receptors in the nervous system
Herz, J., & Bock, H. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135342 · Cited by 457 · see citing works
Gotthardt, M., Trommsdorff, M., Nevitt, M. F., Shelton, J., Richardson, J. A., Stockinger, W., Nimpf, J., & Herz, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000955200 · Cited by 450 · see citing works
Self-citationDomain map of the LDL receptor: Sequence homology with the epidermal growth factor precursor
Russell, D. W., Schneider, W. J., Yamamoto, T., Luskey, K. L., Brown, M. S., & Goldstein, J. L. (1984) · Cell · doi:10.1016/0092-8674(84)90388-x · Cited by 374 · see citing works
Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors
Zelcer, N., Khanlou, N., Clare, R., Jiang, Q., Reed-Geaghan, E. G., Landreth, G. E., Vinters, H. V., & Tontonoz, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701096104 · Cited by 358 · see citing works
Self-citationThe reeler gene encodes a protein with an EGF–like motif expressed by pioneer neurons
Hirotsune, S., Takahara, T., Sasaki, N., Hirose, K., Yoshiki, A., Ohashi, T., Kusakabe, M., Murakami, Y., Muramatsu, M., Watanabe, S., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-77 · Cited by 345 · see citing works
Enzymatic Reduction of Oxysterols Impairs LXR Signaling in Cultured Cells and the Livers of Mice
Chen, W., Chen, G., Head, D. L., Mangelsdorf, D. J., & Russell, D. W. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2006.11.012 · Cited by 316 · see citing works
Sokka, A.-L., Putkonen, N., Mudò, G., Pryazhnikov, E., Reijonen, S., Khiroug, L. S., Belluardo, N., Lindholm, D., & Korhonen, L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4289-06.2007 · Cited by 311 · see citing works
Self-citationKoldamova, R. P., Lefterov, I. M., Staufenbiel, M., Wolfe, D., Huang, S., Glorioso, J. C., Walter, M., Roth, M. G., & Lazo, J. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411420200 · Cited by 279 · see citing works
Poirier, S., Mayer, G., Poupon, V., McPherson, P. S., Desjardins, R., Ly, K., Asselin, M.-C., Day, R. W., Duclos, F. J., Witmer, M. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.037085 · Cited by 273 · see citing works
Tolleshaug, H., Hobgood, K. K., Brown, M. S., & Goldstein, J. L. (1983) · Cell · doi:10.1016/0092-8674(83)90079-x · Cited by 262 · see citing works
Functional Dissection of an Innate Immune Response by a Genome-Wide RNAi Screen
Foley, E., & O'Farrell, P. H. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020203 · Cited by 238 · see citing works
Self-citationReelin signaling directly affects radial glia morphology and biochemical maturation
Hartfuss, E., Förster, E., Bock, H. H., Hack, M. A., Leprince, P., Luque, J. M., Herz, J., Frotscher, M., & Götz, M. (2003) · Development · doi:10.1242/dev.00654 · Cited by 237 · see citing works
PCSK9 binds to multiple receptors and can be functionally inhibited by an EGF-A peptide
Shan, L., Pang, L., Zhang, R., Murgolo, N. J., Lan, H., & Hedrick, J. A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.106 · Cited by 180 · see citing works
Repa, J. J., Li, H., Frank-Cannon, T. C., Valasek, M. A., Turley, S. D., Tansey, M. G., & Dietschy, J. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4823-07.2007 · Cited by 148 · see citing works
Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells
Yang, X. V., Banerjee, Y., Fernández, J. A., Deguchi, H., Xu, X., Mosnier, L. O., Urbanus, R. T., de Groot, P. G., White-Adams, T. C., McCarty, O. J. T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807594106 · Cited by 116 · see citing works
Morales, J. R., Ballesteros, I., Deniz, J. M., Hurtado, O., Vivancos, J., Nombela, F., Lizasoaín, I., Castrillo, A., & Moro, M. Á. (2008) · Circulation · doi:10.1161/circulationaha.108.782300 · Cited by 113 · see citing works
Fan, X., Kim, H.-J., Bouton, D., Warner, M., & Gustafsson, J.-Å. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806974105 · Cited by 103 · see citing works
Living up to a name: the role of the VLDL receptor in lipid metabolism
Tacken, P. J., Hofker, M. H., Havekes, L. M., & van Dijk, K. W. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00006 · Cited by 83 · see citing works
Olsson, P.-A., Korhonen, L., Mercer, E. A., & Lindholm, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36288 · Cited by 77 · see citing works
Self-citationVan Hoof, D., Rodenburg, K. W., & Van der Horst, D. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.00113 · Cited by 53 · see citing works
Self-citationTreatment with LXR agonists after focal cerebral ischemia prevents brain damage
Sironi, L., Mitro, N., Cimino, M., Gelosa, P., Guerrini, U., Tremoli, E., & Sáez, E. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.08.035 · Cited by 50 · see citing works
Mayer, H., Duit, S., Hauser, C., Schneider, W. J., & Nimpf, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.19-27.2006 · Cited by 39 · see citing works
Self-citationSakai, K., Tiebel, O., Ljungberg, M. C., Sullivan, M., Lee, H.-J., Terashima, T., Li, R., Kobayashi, K., Lu, H.-C., Chan, L., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.030 · Cited by 23 · see citing works
Interactions of DNR1 with the apoptotic machinery of<i>Drosophila</i>melanogaster
Primrose, D. A., Chaudhry, S., Johnson, A. G. D., Hrdlicka, A., Schindler, A., Tran, D., & Foley, E. (2007) · Journal of Cell Science · doi:10.1242/jcs.03417 · Cited by 15 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms and regulation of cholesterol homeostasis
Luo, J., Yang, H., & Song, B.-L. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0190-7 · Cited by 1,980 · see citing works
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
Calkin, A. C., & Tontonoz, P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3312 · Cited by 779 · see citing works
Self-citationLiver X receptors in lipid signalling and membrane homeostasis
Wang, B., & Tontonoz, P. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0037-x · Cited by 722 · see citing works
Self-citationLipid metabolism in cancer progression and therapeutic strategies
Fu, Y., Zou, T., Shen, X., Nelson, P. J., Li, J., Wu, C., Yang, J., Zheng, Y., Bruns, C. J., Zhao, Y., et al. (2020) · MedComm · doi:10.1002/mco2.27 · Cited by 406 · see citing works
Cargo Recognition in Clathrin-Mediated EndocytosisPreprint
Traub, L. M., & Bonifacino, J. S. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016790 · Cited by 322 · see citing works
Mudó, G., Mäkelä, J., Liberto, V. D., Tselykh, T. V., Olivieri, M., Piepponen, P., Eriksson, O., Mälkiä, A., Bonomo, A., Kairisalo, M., et al. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0850-z · Cited by 315 · see citing works
Self-citationLiver X Receptor Signaling Pathways and Atherosclerosis
Calkin, A. C., & Tontonoz, P. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.191197 · Cited by 294 · see citing works
Self-citationChasman, D. I., Giulianini, F., MacFadyen, J., Barratt, B. J., Nyberg, F., & Ridker, P. M. (2012) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.111.961144 · Cited by 285 · see citing works
Regulation of cholesterol homeostasis
Goedeke, L., & Fernandez-Hernando, C. F. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0857-5 · Cited by 216 · see citing works
LXR Regulation of Brain Cholesterol: From Development to Disease
Courtney, R., & Landreth, G. E. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.03.018 · Cited by 176 · see citing works
The Challenges and Promise of Targeting the Liver X Receptors for Treatment of Inflammatory Disease
Fessler, M. (2017) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2017.07.010 · Cited by 160 · see citing works
Molecular Pathways Underlying Cholesterol Homeostasis
Afonso, M., Machado, R., Lavrador, M. S., Quintão, E., Moore, K., & Lottenberg, A. M. (2018) · Nutrients · doi:10.3390/nu10060760 · Cited by 141 · see citing works
New insights into Reelin-mediated signaling pathways
Lee, G. H., & D’Arcangelo, G. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00122 · Cited by 144 · see citing works
Liver X receptors as regulators of macrophage inflammatory and metabolic pathways
A-González, N., & Castrillo, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.015 · Cited by 139 · see citing works
PCSK9 regulates neuronal apoptosis by adjusting ApoER2 levels and signaling
Kysenius, K., Muggalla, P., Mätlik, K., Arumäe, U., & Huttunen, H. J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0977-6 · Cited by 137 · see citing works
Feedback Regulation of Cholesterol Uptake by the LXR–IDOL–LDLR Axis
Zhang, L., Reue, K., Fong, L. G., Young, S. G., & Tontonoz, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.250571 · Cited by 137 · see citing works
Self-citationCholesterol in LDL receptor recycling and degradation
Hui-xian, Y., Zhang, M., Long, S., Tuo, Q., Tian, Y., Chen, J., Zhang, C., & Liao, D. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.09.022 · Cited by 104 · see citing works
Role of gut microbiota in the modulation of atherosclerosis-associated immune response
Chistiakov, D. A., Bobryshev, Y. V., Kozarov, E. V., Sobenin, I. A., & Orekhov, A. N. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00671 · Cited by 101 · see citing works
Similarities and differences in structure, expression, and functions of VLDLR and ApoER2
Reddy, S. S., Connor, T. E., Weeber, E. J., & Rebeck, W. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-30 · Cited by 93 · see citing works
The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor
Dlugosz, P., & Nimpf, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103090 · Cited by 91 · see citing works
Self-citationNDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation
Pietiäinen, V. M., Vassilev, B., Blom, T., Wang, W., Nelson, J. K., Bittman, R., Bäck, N., Zelcer, N., & Ikonen, E. (2013) · Journal of Cell Science · doi:10.1242/jcs.128132 · Cited by 84 · see citing works
Self-citationZheng, W., Mast, N., Saadane, A., & Pikuleva, I. A. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m053439 · Cited by 80 · see citing works
Scotti, E., Calamai, M., Goulbourne, C. N., Zhang, L., Hong, C., Lin, R. R., Choi, J., Pilch, P. F., Fong, L. G., Zou, P., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01716-12 · Cited by 80 · see citing works
Self-citationHsieh, V., Kim, M., Gelissen, I. C., Brown, A. J., Sandoval, C., Hallab, J., Kockx, M., Traini, M. D., Jessup, W., & Kritharides, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.515890 · Cited by 79 · see citing works
Scotti, E., Hong, C., Yoshinaga, Y., Tu, Y., Hu, Y., Zelcer, N., Boyadjian, R., de Jong, P. J., Young, S. G., Fong, L. G., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01469-10 · Cited by 77 · see citing works
Self-citationThe UPS and downs of cholesterol homeostasis
Sharpe, L. J., Cook, E. C. L., Zelcer, N., & Brown, A. J. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.08.008 · Cited by 76 · see citing works
Self-citationAbnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis
Omarova, S., Charvet, C. D., Reem, R. E., Mast, N., Zheng, W., Huang, S., Peachey, N. S., & Pikuleva, I. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63816 · Cited by 74 · see citing works
Biliary and nonbiliary contributions to reverse cholesterol transport
Temel, R. E., & Brown, J. M. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283508c21 · Cited by 73 · see citing works
Thi, H., Tselykh, T. V., Mäkelä, J., Ho, T. H., Olkkonen, V. M., Bornhauser, B. C., Korhonen, L., Zelcer, N., & Lindholm, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.341248 · Cited by 67 · see citing works
Self-citationLiu, S., & Vaziri, N. D. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft439 · Cited by 67 · see citing works
Sorrentino, V., Nelson, J. K., Maspero, E., Marques, A. R. A., Scheer, L., Polo, S., & Zelcer, N. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m037713 · Cited by 66 · see citing works
Self-citationThe ubiquitous role of ubiquitination in lipid metabolism
Loix, M., Zelcer, N., Bogie, J. F. J., & Hendriks, J. J. A. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.09.001 · Cited by 64 · see citing works
Self-citationZhao, N., Zhang, A., Worthen, C., Knutson, M. D., & Enns, C. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405355111 · Cited by 64 · see citing works
Calkin, A. C., Goult, B. T., Zhang, L., Fairall, L., Hong, C., Schwabe, J. W. R., & Tontonoz, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111589108 · Cited by 62 · see citing works
Self-citationBoth K63 and K48 ubiquitin linkages signal lysosomal degradation of the LDL receptor
Zhang, L., Xu, M., Scotti, E., Chen, Z. J., & Tontonoz, P. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035774 · Cited by 64 · see citing works
Self-citationCeroi, A., Masson, D., Roggy, A., Roumier, C., Chagué, C., Gauthier, T., Philippe, L., Lamarthée, B., Angelot‐Delettre, F., Bonnefoy, F., et al. (2016) · Blood · doi:10.1182/blood-2016-06-724807 · Cited by 64 · see citing works
Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome
Vacca, M., Degirolamo, C., Mariani‐Costantini, R., Palasciano, G., & Moschetta, A. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.137 · Cited by 63 · see citing works
Dubé, É., Éthier‐Chiasson, M., & Lafond, J. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.112.105619 · Cited by 62 · see citing works
ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease
Li, Y., Macyczko, J. R., Liu, C.-C., & Bu, G. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.011 · Cited by 61 · see citing works
Blockade of cholesterol absorption by ezetimibe reveals a complex homeostatic network in enterocytes
Engelking, L. J., McFarlane, M., Li, C. K., & Liang, G. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m027599 · Cited by 60 · see citing works
Roubtsova, A., Chamberland, A., Marcinkiewicz, J., Essalmani, R., Fazel, A., Bergeron, J. J. M., Seidah, N. G., & Prat, A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m061952 · Cited by 58 · see citing works
Sorrentino, V., Fouchier, S. W., Motazacker, M. M., Nelson, J. K., Defesche, J. C., Dallinga‐Thie, G. M., Kastelein, J. J. P., Hovingh, G. K., & Zelcer, N. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs472 · Cited by 58 · see citing works
Self-citationSorrentino, V., & Zelcer, N. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283532947 · Cited by 55 · see citing works
Self-citationChen, Y. Q., Troutt, J. S., & Konrad, R. J. (2014) · Lipids · doi:10.1007/s11745-014-3895-6 · Cited by 56 · see citing works
Sorrentino, V., Scheer, L., Santos, A., Reits, E., Bleijlevens, B., & Zelcer, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.249557 · Cited by 53 · see citing works
Self-citationThe Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOL
Nelson, J. K., Sorrentino, V., Trezza, R. A., Heride, C., Urbé, S., Distel, B., & Zelcer, N. (2015) · Circulation Research · doi:10.1161/circresaha.115.307298 · Cited by 51 · see citing works
Self-citationSorting nexin 17 regulates ApoER2 recycling and reelin signaling
Sotelo, P., Farfán, P., Benitez, M. L., Bu, G., & Marzolo, M.-P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093672 · Cited by 47 · see citing works
Loregger, A., Cook, E. C. L., Nelson, J. K., Moeton, M., Sharpe, L. J., Engberg, S., Karimova, M., Lambert, G. C., Brown, A. J., & Zelcer, N. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00890-15 · Cited by 47 · see citing works
Self-citationTranscriptional and Posttranscriptional Control of Cholesterol Homeostasis by Liver X ReceptorsPreprint
Tontonoz, P. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010702 · Cited by 46 · see citing works
Self-citationThe hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance
Wijers, M., Zanoni, P., Liv, N., Vos, D. Y., Jäckstein, M. Y., Smit, M., Wilbrink, S., Wolters, J. C., van der Veen, Y. T., Huijkman, N., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126462 · Cited by 41 · see citing works
Ubiquitin-mediated regulation of sterol homeostasis
van den Boomen, D. J. H., Volkmar, N., & Lehner, P. J. (2020) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2020.04.010 · Cited by 41 · see citing works
Liver X receptors, nervous system, and lipid metabolism.
Cermenati, G., Brioschi, E., Abbiati, F., Melcangi, R. C., Caruso, D., & Mitro, N. (2013) · PubMed · doi:10.3275/8941 · Cited by 40 · see citing works
Liu, J. (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2010.559 · Cited by 39 · see citing works
Liver X receptors agonists impede hepatitis C virus infection in an Idol-dependent manner
Zeng, J., Wu, Y., Liao, Q., Li, L., Chen, X., & Chen, X. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.06.004 · Cited by 39 · see citing works
Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases
Griffett, K., & Burris, T. P. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1102469 · Cited by 37 · see citing works
Thi, H., Bruelle, C., Pham, D. D., Jauhiainen, M., Eriksson, O., Korhonen, L., & Lindholm, D. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13397 · Cited by 36 · see citing works
Self-citationExtracellular proteolysis of reelin by tissue plasminogen activator following synaptic potentiation
Trotter, J. H., Lussier, A. L., Psilos, K. E., Mahoney, H. L., Sponaugle, A., Hoe, H., Rebeck, G. W., & Weeber, E. J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.046 · Cited by 35 · see citing works
Choi, Y., Lee, S. J., Kim, H. I., Lee, H. J., Kang, S.-J., Kim, T. Y., Cheon, C., & Ko, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-76224-w · Cited by 34 · see citing works
FE65 as a link between VLDLR and APP to regulate their trafficking and processing
Dumanis, S. B., Chamberlain, K. A., Sohn, Y. J., Lee, Y. J., Guénette, S. Y., Suzuki, T., Mathews, P. M., Pak, D. T. S., Rebeck, G. W., Suh, Y., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-9 · Cited by 34 · see citing works
Balancing cholesterol in the brain: from synthesis to disposal
Qian, L., Chai, A. B., Gelissen, I. C., & Brown, A. J. (2022) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2022.00015 · Cited by 36 · see citing works
Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease
Kim, H.-J., Park, C., & Kim, T. H. (2023) · Cells · doi:10.3390/cells12091292 · Cited by 32 · see citing works
Liu, Y., Zhang, X., Yu, L., Cao, L., Zhang, J., Li, Q., Wang, X., Qi, W., Cai, L., Ren, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57404-6 · Cited by 32 · see citing works
Suon, S., Zhao, J. J., Villarreal, S. A., Anumula, N., Liu, M., Carangia, L. M., Renger, J. J., & Zerbinatti, C. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-44 · Cited by 30 · see citing works
Gao, J., Marosi, M., Choi, J., Achiro, J. M., Kim, S., Li, S., Otis, K., Martin, K. C., Portera-Cailliau, C., & Tontonoz, P. (2017) · eLife · doi:10.7554/elife.29178 · Cited by 30 · see citing works
Self-citationPathways and Molecular Mechanisms Governing LDL Receptor Regulation
Schmidt, H. M., Jarrett, K. E., Vallim, T. Q. D. A., & Tarling, E. J. (2025) · Circulation Research · doi:10.1161/circresaha.124.323578 · Cited by 29 · see citing works
PCSK9: A potential regulator of apoE/apoER2 against inflammation in atherosclerosis?
Bai, X.-Q., Peng, J., Wang, M., Xiao, J. H., Xiang, Q., Ren, Z., Wen, H.-Y., Jiang, Z., Tang, Z., & Liu, L. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.04.040 · Cited by 29 · see citing works
van Loon, N. M., Ottenhoff, R., Kooijman, S., Moeton, M., Scheij, S. S., Abbing, R. L. P. R., Gijbels, M. J., Levels, J. H. M., Sorrentino, V., Berbée, J. F. P., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311168 · Cited by 28 · see citing works
Self-citationA review of gene- and cell-based therapies for familial hypercholesterolemia
Hajighasemi, S., Gorabi, A. M., Bianconi, V., Pirro, M., Banach, M., Tafti, S. H. A., Reiner, Ž., & Sahebkar, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.016 · Cited by 28 · see citing works
Sasaki, M., Terao, Y., Ayaori, M., Uto‐Kondo, H., Iizuka, M., Yogo, M., Hagisawa, K., Takiguchi, S., Yakushiji, E., Nakaya, K., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302670 · Cited by 28 · see citing works
Nuclear receptor mediated mechanisms of macrophage cholesterol metabolism
Nagy, Z. S., Czimmerer, Z., & Nagy, L. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.003 · Cited by 27 · see citing works
Pham, D. D., Bruelle, C., Thi, H., Pajanoja, C., Jin, C., Srinivasan, V., Olkkonen, V. M., Eriksson, O., Jauhiainen, M., Lalowski, M. M., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1758-z · Cited by 27 · see citing works
Self-citationExpression of CNPY2 in Mouse Tissues: Quantification and Localization
Hatta, K., Guo, J., Lüdke, A., Dhingra, S., Singh, K., Huang, M., Weisel, R. D., & Li, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111370 · Cited by 27 · see citing works
Saas, P., Varin, A., Perruche, S., & Ceroi, A. (2017) · F1000Research · doi:10.12688/f1000research.11332.2 · Cited by 27 · see citing works
IDOL regulates systemic energy balance through control of neuronal VLDLR expression
Lee, S. D., Priest, C., Bjursell, M., Gao, J., Arneson, D. V., Ahn, I. S., Diamante, G., van Veen, J. E., Massa, M. G., Calkin, A. C., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0127-7 · Cited by 26 · see citing works
Self-citationQu, L., Li, D., Gao, X., Li, Y., Wu, J., & Zou, W. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01170 · Cited by 25 · see citing works
SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1
Wang, J.-Q., Lin, Z., Li, L., Zhang, S.-Y., Li, W., Liu, W., Song, B.-L., & Luo, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015420 · Cited by 22 · see citing works
van Loon, N. M., Lindholm, D., & Zelcer, N. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000593 · Cited by 23 · see citing works
Self-citationThe Role of Ubiquitin E3 Ligase in Atherosclerosis
Zhou, Z., Ren, Z., Yan, B., Qu, S.-L., Tang, Z., Wei, D., Liu, L.-S., Fu, M., & Jiang, Z. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200306124418 · Cited by 23 · see citing works
Powerful and efficient SNP-set association tests across multiple phenotypes using GWAS summary data
Guo, B., & Wu, B. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty811 · Cited by 23 · see citing works
Nelson, J. K., Cook, E. C. L., Loregger, A., Hoeksema, M. A., Scheij, S. S., Kovačević, I., Hordijk, P. L., Ovaa, H., & Zelcer, N. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698688 · Cited by 23 · see citing works
Self-citationStarr, A. E., Lemieux, V., Noad, J., Moore, J. I., Dewpura, T., Raymond, A., Chrétien, M., Figeys, D., & Mayne, J. (2015) · FEBS Journal · doi:10.1111/febs.13309 · Cited by 22 · see citing works
Pham, D. D., Thi, H., Bruelle, C., Kukkonen, J. P., Eriksson, O., Mogollón, I., Korhonen, L., Arumäe, U., & Lindholm, D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.722272 · Cited by 21 · see citing works
Self-citationDo, H. T., Bruelle, C., Tselykh, T., Jalonen, P., Korhonen, L., & Lindholm, D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.500967 · Cited by 20 · see citing works
Self-citationRegulation of intestinal LDLR by the LXR-IDOL axis
van Loon, N. M., van Wouw, S. A. E., Ottenhoff, R., Nelson, J. K., Kingma, J., Scheij, S. S., Moeton, M., & Zelcer, N. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.10.898 · Cited by 19 · see citing works
Self-citationSaas, P., Varin, A., Perruche, S., & Ceroi, A. (2017) · F1000Research · doi:10.12688/f1000research.11332.1 · Cited by 19 · see citing works
Degradation routes of trafficking-defective VLDLR mutants associated with Dysequilibrium syndrome
Kizhakkedath, P., John, A., Al‐Gazali, L., & Ali, B. R. (2018) · Scientific Reports · doi:10.1038/s41598-017-19053-8 · Cited by 17 · see citing works
The low-density lipoprotein receptor: Emerging post-transcriptional regulatory mechanisms
Ndoj, K., Meurs, A., Papaioannou, D., Bjune, K., & Zelcer, N. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.119082 · Cited by 16 · see citing works
Self-citationImagawa, M., Takahashi, S., Zenimaru, Y., Kimura, T., Suzuki, J., Miyamori, I., Iwasaki, T., Hattori, H., Yamamoto, T. T., Nakano, T., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.10.033 · Cited by 16 · see citing works
Yu, Q., Zheng, H., & Zhang, Y. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106878 · Cited by 16 · see citing works
Koivuniemi, R., Mäkelä, J., Hokkanen, M., Bruelle, C., Ho, T. H., Ola, R., Korhonen, L., Schröder, J., Kataoka, H., & Lindholm, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056117 · Cited by 15 · see citing works
Self-citationRole of ubiquitination in PCSK9-mediated low-density lipoprotein receptor degradation
Chen, Y., Wang, H., Yu, L., Yu, X., Qian, Y., Cao, G., & Wang, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.110 · Cited by 15 · see citing works
Martinelli, L., Adamopoulos, A., Johansson, P., Wan, P., Gunnarsson, J., Guo, H., Boyd, H., Zelcer, N., & Sixma, T. K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014349 · Cited by 14 · see citing works
Self-citationNovel genes in LDL metabolism – a comprehensive overview
Christoffersen, M., & Tybjærg‐Hansen, A. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000175 · Cited by 13 · see citing works
Kizhakkedath, P., Loregger, A., John, A., Bleijlevens, B., Al-Blooshi, A. S., Al-Hosani, A. H., Al-Nuaimi, A. M., Al‐Gazali, L., Zelcer, N., & Ali, B. R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.08.013 · Cited by 13 · see citing works
Self-citationRen, Z., Zhou, J., Yang, D., Guo, Y., Zhang, J., Xu, J., & Chen, Y. E. (2026) · Cells · doi:10.3390/cells15020134 · Cited by 13 · see citing works
Stable liver-specific expression of human IDOL in humanized mice raises plasma cholesterol
Ibrahim, S., Somanathan, S., Billheimer, J. T., Wilson, J. M., & Rader, D. J. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw010 · Cited by 12 · see citing works
Walsh, S. C., Miles, J. R., Keel, B. N., Rempel, L. A., Wright-Johnson, E. C., Lindholm‐Perry, A. K., Oliver, W. T., & Pannier, A. K. (2022) · Molecular Reproduction and Development · doi:10.1002/mrd.23553 · Cited by 9 · see citing works
Unlocking the genome of perch – From genes to ecology and back again
Vasemägi, A., Ozerov, M. Y., Noreikienė, K., López, M., & Gårdmark, A. (2023) · Ecology Of Freshwater Fish · doi:10.1111/eff.12713 · Cited by 9 · see citing works
Yan, T.-T., Yin, R., Li, Q., Huang, P., Zeng, X., Huang, K., Wu, D., & Aung, L. H. H. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-141 · Cited by 9 · see citing works
FERM domain–containing proteins are active components of the cell nucleus
Borkúti, P., Kristó, I., Szabó, A., Kovács, Z., & Vilmos, P. (2024) · Life Science Alliance · doi:10.26508/lsa.202302489 · Cited by 8 · see citing works
- Authors
- Hong, C., Duit, S., Jalonen, P., Out, R., Scheer, L., Sorrentino, V., Boyadjian, R., Rodenburg, K. W., Foley, E., Korhonen, L., Lindholm, D., Nimpf, J., van Berkel, T. J. C., Tontonoz, P., & Zelcer, N.
- Affiliations
- Howard Hughes Medical Institute (US)
- Max Perutz Labs (AT)
- Minerva Foundation (FI)
- Leiden University (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Utrecht University (NL)
- University of Alberta (CA)
- University of Helsinki (FI)
- Corresponding author
- Zelcer, Noam
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 285
- Issue
- 26
- Pages
- 19720-19726
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2888382
- OpenAlex
- W2164276007
- Semantic Scholar
- 0b069956933d85443eeb045d415d6c60b0697071
- Cited by
- 142
- References
- 43
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 5 · 2023: 7 · 2022: 7 · 2021: 2 · 2020: 7 · 2019: 8 · 2018: 12 · 2017: 4 · 2016: 7 · 2015: 10 · 2014: 12 · 2013: 10 · 2012: 17
- FWCI
- 14.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Academy of Finland
- Fondation pour la Recherche Médicale
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Herzfelder'sche Familienstiftung
- National Institutes of Health (HL090553)
- Canadian Institutes of Health Research
- National Heart, Lung, and Blood Institute (P01HL090553, HL066088, HL090553, R01HL066088)
- Topics
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- idols, E3 ubiquitin ligase, VLDLR, ApoER2, liver X receptor, receptor degradation, ubiquitination, Reelin signaling, neuronal development, lipid metabolism
- MeSH terms
- Liver X Receptors, Reelin Protein, Benzenesulfonamides, Animals, Benzoates, Benzylamines, Cell Line, Fluorocarbons, Humans, Hydrocarbons, Fluorinated, Mice, Inbred C57BL, Nerve Tissue Proteins, Phosphorylation, Protein Binding, Receptors, LDL, Serine Endopeptidases, Sulfonamides, Transfection, Immunoblotting, Signal Transduction, Cell Adhesion Molecules, Neuronal, Extracellular Matrix Proteins, Receptors, Lipoprotein, Mice, Knockout, LDL-Receptor Related Proteins, NIH 3T3 Cells, Ubiquitin-Protein Ligases, Cell Line, Tumor, Mice, Ubiquitination, Orphan Nuclear Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-02.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-02.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review